T Cell Therapies for Autoimmune Indications Webinar
The immune tolerance landscape is nothing but dynamic; in our recent webinar, our expert panel discussed the obstacles in treating autoimmune diseases with T Cell therapy approaches and the strategies the developers are utilizing to overcome these obstacles. Key aspects explored included:
- A comprehensive overview of the competitive T Cell therapy within the immune-mediated disease space
- Insights into the emerging trends of Treg therapies
- A picture of what we can likely expect ahead based on recent approvals and late-stage activity
Our Experts
Rachel Hourigan
House Speaker
Lead Research Analyst
Beacon
Luka Vukoje
Moderator
Account Manager
Beacon
You May Also Be Interested In…
Learn More About Cell Therapy
What is Beacon Cell Therapy?
- The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
- Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
